Evidence map›Paper›PMID 24965469›Full record

ArticleJournal of virology2014

Impaired Nef function is associated with early control of HIV-1 viremia.

Xiaomei T Kuang, Xiaoguang Li, Gursev Anmole, Philip Mwimanzi, Aniqa Shahid, Anh Q Le, Louise Chong, Hua Qian, Toshiyuki Miura, Tristan Markle and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Modelling andVirus evolution · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 4 countries.

Xiaomei T KuangDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
Xiaoguang LiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Gursev AnmoleDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
Philip MwimanziDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Aniqa ShahidFaculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Anh Q LeFaculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Louise ChongDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
Hua QianCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Toshiyuki MiuraRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Tristan MarkleDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
Bemuluyigza BarakiDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Elizabeth ConnickDepartment of Medicine, University of Colorado-Denver, Denver, Colorado, USA.
Eric S DaarDavid Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA.
Heiko JessenJessen-Jessen Praxis, Berlin, Germany.
Anthony D KelleherKirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia.
Susan LittleDivision of Infectious Diseases, University of California, San Diego, San Diego, USA.
Martin MarkowitzAaron Diamond AIDS Research Center, New York, New York, USA.
Florencia PereyraRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Eric S RosenbergDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Bruce D WalkerRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
Takamasa UenoCenter for AIDS Research, Kumamoto University, Kumamoto, Japan International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
Zabrina L BrummeFaculty of Health Sciences, Simon Fraser University, Burnaby, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Mark A BrockmanDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada mark_brockman@sfu.ca.
Simon Fraser University · CAKumamoto University · JPRagon Institute of MGH, MIT and Harvard · USAIDS Vancouver · CAAaron Diamond AIDS Research Center · USMassachusetts General Hospital · USUniversity of California, Los Angeles · USUniversity of California, San Diego · USUniversity of Colorado Denver · USUNSW Sydney · AU

Funding

Primary Infection Resource Consortium (PIRC)R24AI106039 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITTLE, SUSAN JANET · 2013 to 2021
$23.1M
CIHR MOP-93536CIHR THA-118569NIAID NIH HHS R24 AI106039
6 · The paper itself

Abstract

unlabelledHost and viral factors influence the HIV-1 infection course. Reduced Nef function has been observed in HIV-1 controllers during the chronic phase, but the kinetics and mechanisms of Nef attenuation in such individuals remain unclear. We examined plasma RNA-derived Nef clones from 10 recently infected individuals who subsequently suppressed viremia to less than 2,000 RNA copies/ml within 1 year postinfection (acute controllers) and 50 recently infected individuals who did not control viremia (acute progressors). Nef clones from acute controllers displayed a lesser ability to downregulate CD4 and HLA class I from the cell surface and a reduced ability to enhance virion infectivity compared to those from acute progressors (all P<0.01). HLA class I downregulation activity correlated inversely with days postinfection (Spearman's R=-0.85, P=0.004) and positively with baseline plasma viral load (Spearman's R=0.81, P=0.007) in acute controllers but not in acute progressors. Nef polymorphisms associated with functional changes over time were identified in follow-up samples from six controllers. For one such individual, mutational analyses indicated that four polymorphisms selected by HLA-A*31 and B*37 acted in combination to reduce Nef steady-state protein levels and HLA class I downregulation activity. Our results demonstrate that relative control of initial HIV-1 viremia is associated with Nef clones that display reduced function, which in turn may influence the course of HIV-1 infection. Transmission of impaired Nef sequences likely contributed in part to this observation; however, accumulation of HLA-associated polymorphisms in Nef that impair function also suggests that CD8+ T-cell pressures play a role in this phenomenon. IMPORTANCE: Rare individuals can spontaneously control HIV-1 viremia in the absence of antiretroviral treatment. Understanding the host and viral factors that contribute to the controller phenotype may identify new strategies to design effective vaccines or therapeutics. The HIV-1 Nef protein enhances viral pathogenesis through multiple mechanisms. We examined the function of plasma HIV-1 RNA-derived Nef clones isolated from 10 recently infected individuals who subsequently controlled HIV viremia compared to the function of those from 50 individuals who failed to control viremia. Our results demonstrate that early Nef clones from HIV controllers displayed lower HLA class I and CD4 downregulation activity, as well as a reduced ability to enhance virion infectivity. The accumulation of HLA-associated polymorphisms in Nef during the first year postinfection was associated with impaired protein function in some controllers. This report highlights the potential for host immune responses to modulate HIV pathogenicity and disease outcome by targeting cytotoxic T lymphocyte (CTL) epitopes in Nef.

Indexed as

CD4 AntigensDown-RegulationGenotypeHistocompatibility Antigens Class IHIV-1HIV InfectionsHumansMolecular Sequence Datanef Gene Products, Human Immunodeficiency VirusPlasmaPolymorphism, GeneticRNA, ViralSequence Analysis, DNAViral LoadViremiaCD4 AntigensHistocompatibility Antigens Class Inef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1RNA, Viral

Identifiers

PMID24965469
PMCPMC4136354
OpenAlexW2169992693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.